Evidence map›Paper›PMID 41117802›Full record

ArticleThe Journal of experimental medicine2026

Oral antigen exposure under costimulation blockade induces Treg cells to establish immune tolerance.

Masaya Arai, Ryoji Kawakami, Yamami Nakamura, Yoko Naito, Daisuke Motooka, Atsushi Sugimoto, Tomiko Kimoto, Naganari Ohkura, Norihisa Mikami, Shimon Sakaguchi

Abstract read
In one paragraph

Article in The Journal of experimental medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Masaya Arai *Department of Experimental Immunology, Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.ORCID 0000-0002-0876-7842
Ryoji Kawakami *Department of Experimental Immunology, Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.ORCID 0000-0003-2253-4559
Yamami NakamuraDepartment of Experimental Immunology, Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.ORCID 0009-0009-4213-4473
Yoko NaitoGenome Information Research Center, Research Institute for Microbial Diseases, The University of Osaka , Osaka, Japan.ORCID 0000-0003-1512-3313
Daisuke MotookaGenome Information Research Center, Research Institute for Microbial Diseases, The University of Osaka , Osaka, Japan.ORCID 0000-0002-4616-9608
Atsushi SugimotoDepartment of Experimental Immunology, Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.ORCID 0009-0008-2110-6011
Tomiko KimotoDepartment of Experimental Immunology, Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.ORCID 0009-0005-3521-5655
Naganari OhkuraDepartment of Experimental Immunology, Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.ORCID 0000-0002-6656-6942
Norihisa MikamiDepartment of Experimental Immunology, Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.ORCID 0000-0001-6360-5363
Shimon SakaguchiDepartment of Experimental Immunology, Immunology Frontier Research Center, The University of Osaka, Osaka, Japan.ORCID 0000-0001-8265-6094

Funding

Japan Society for the Promotion of Science 16H06295Japan Society for the Promotion of Science 20J20443Japan Society for the Promotion of Science 20K16279Japan Society for the Promotion of Science 23H02733Japan Society for the Promotion of Science 24H00610Kyoto UniversityLeading Advanced Projects for Medical Innovation 18gm0010005Nipponham Foundation for the Future of Food
6 · The paper itself

Abstract

Antigen-specific oral tolerance prevents harmful immune responses in naïve animals but is difficult to induce in antigen-primed hosts. Here, we showed that feeding of antigen-containing diet generated peripherally derived regulatory T (pTreg) cells with tissue-adapted effector properties. They acquired Treg-specific epigenomic changes at Treg signature genes, including Foxp3, exhibiting stable suppressive function. Cessation of antigen feeding diminished pTreg cells, hampering tolerance induction. Notably, pTreg cells induced by antigen feeding predominantly expressed CD101. CD101+ Treg cells with similar phenotypic and epigenetic features could also be generated in vitro from antigen-primed naïve CD4+ T cells by blocking CD28-mediated costimulation during TGF-β-dependent Treg induction. Furthermore, in mice already antigen-sensitized by nonoral routes, in vivo blockade of CD28 signaling with CTLA4-Ig prior to antigen feeding promoted differentiation of antigen-specific T cells into CD101+ pTreg cells, facilitating oral tolerance. Thus, continuous oral antigen exposure combined with CD28 blockade generates functionally stable CD101+ pTreg cells, thereby establishing systemic antigen-specific tolerance even in antigen-presensitized hosts.

Indexed as

AntigensImmune ToleranceT-Lymphocytes, RegulatoryAdministration, OralAnimalsCD28 AntigensForkhead Transcription FactorsMiceMice, Inbred C57BLTransforming Growth Factor betaAntigensCD28 AntigensForkhead Transcription FactorsTransforming Growth Factor beta

Identifiers

PMID41117802
PMCPMC12539616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.